CoChat

Light Therapy for Patients With Bipolar Depression: Systematic Review and Meta-Analysis of Randomized Controlled Trials

Open access

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index; 11 of the 41 sources its claims cite were checked for support.

Abstract

Objective Bipolar disorder (BD) is challenging to treat, and fewer treatments are available for depressive episodes compared to mania. Light therapy is an evidence-based nonpharmacological treatment for seasonal and nonseasonal major depression, but fewer studies have examined its efficacy for patients with BD. Hence, we reviewed the evidence for adjunctive light therapy as a treatment for bipolar depression. Methods We conducted a systematic review of databases from inception to June 30, 2019, for randomized, double-blind, placebo-controlled trials of light therapy in patients with BD (CRD42019128996). The primary outcome was change in clinician-rated depressive symptom score; secondary outcomes included clinical response, remission, acceptability, and treatment-emergent mood switches. We quantitatively pooled outcomes using meta-analysis with random-effects models. Results We identified seven trials representing 259 patients with BD. Light therapy was associated with a significant improvement in Hamilton Depression Rating Scale score (standardized mean difference = 0.43, 95% confidence interval [CI], 0.04 to 0.82, P = 0.03). There was also a significant difference in favor of light therapy for clinical response (odds ratio [ OR] = 2.32; 95% CI, 1.12 to 4.81; P = 0.024) but not for remission. There was no difference in affective switches between active light and control conditions ( OR = 1.30; 95% CI, 0.38 to 4.44; P = 0.67). Study limitations included different light treatment parameters, small sample sizes, short treatment durations, and variable quality across trials. Conclusion There is positive but nonconclusive evidence that adjunctive light therapy reduces symptoms of bipolar depression and increases clinical response. Light therapy is well tolerated with no increased risk of affective switch.

Overview

CoChat Summary

## TL;DR

This systematic review and meta-analysis found that adjunctive light therapy for bipolar depression had positive but nonconclusive evidence: it improved clinician-rated depressive symptoms and clinical response, with no detected increase in affective switch. The evidence base was small and heterogeneous, with 7 trials and 259 participants.

## Key findings

  • Across 7 trials (259 participants), active light therapy improved clinician-rated depressive symptoms on the HAM-D versus control: SMD 0.43, 95% CI 0.04 to 0.82, P = 0.03.
  • Clinical response favored light therapy in 6 trials: pooled OR 2.32, 95% CI 1.12 to 4.81, P = 0.024; overall response rates were 64.3% with active light vs 42.9% with control.
  • Clinical remission was not statistically significant in 5 trials: pooled OR 3.21, 95% CI 0.83 to 12.4, P = 0.09; remission rates were 40.7% vs 16.9%.
  • No significant increase in affective switch was found in 7 trials: OR 1.30, 95% CI 0.38 to 4.44, P = 0.67; switch rates were 3.0% vs 1.6%.

## Methods

  • Systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of adjunctive light therapy in patients with bipolar disorder in a depressive episode; registered at PROSPERO (CRD42019128996).
  • Searches covered inception to June 30, 2019 across Web of Science, EMBASE, Medline, PsycInfo, and Clinicaltrials.gov, plus reference chaining and Google Scholar.
  • Primary analysis pooled endpoint clinician-rated depressive symptom change using standardized mean differences with random-effects models; secondary outcomes included response, remission, discontinuation, and treatment-emergent mood switches.

## Limitations

  • The paper states the included studies had variable quality, heterogeneous light parameters, small sample sizes, short follow-up, and some control conditions may have had active effects.
  • Risk of bias was high or unclear in at least one major category across studies; 4 of 7 trials did not report allocation concealment, and only 4 reported blinded outcome raters.
  • Evident from the text: most participants were also taking concomitant medications and the studies did not separate BD-I from BD-II data, limiting subgroup-specific inference.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1177/0706743719892471

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

11 Valid · 0 Not valid · 13 Not checked · 77 Own results and interpretations

35 more claims

Create a free account to see all 101 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 34
  • It may state two separate claims as one. 39
  • The quote only partly states this claim. 2

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

4 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 36 references

Research works printed but not linked: 2

  1. Penders TM, 2016, Prim Care Companion CNS Disord, 18
  2. Higgins J, 2011, Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]

Cited by

See all 72

Metadata

Authors
Lam, R. W., Teng, M. Y., Jung, Y.-E., Evans, V. C., Gottlieb, J. F., Chakrabarty, T., Michalak, E. E., Murphy, J. K., Yatham, L. N., & Sit, D. K.
Affiliations
  • University of British Columbia (CA)
  • Northwestern University (US)
Corresponding author
Lam, Raymond W.
Venue
The Canadian Journal of Psychiatry
Published
2019-12-12
Volume
65
Issue
5
Pages
290-300
ISSN
  • 0706-7437 (ISSN-L)
  • 1497-0015
OpenAlex
W2996702796
Cited by
70
References
35
Citations by year
2026: 16 · 2025: 15 · 2024: 6 · 2023: 10 · 2022: 10 · 2021: 11 · 2020: 2
FWCI
0.82
Type
journal article
Language
en
Open access
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • The Canadian Journal of Psychiatry (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
Keywords
phototherapy, bipolar depression, bipolar disorder, adjunctive therapy, depressive symptoms, clinical response, mood switching, treatment acceptability, non-pharmacological treatment
MeSH terms
Bipolar Disorder, Major Depressive Disorder, Double-Blind Method, Humans, Phototherapy, Randomized Controlled Trials as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-03, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-03 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Light Therapy for Patients With Bipolar Depression: Systematic Review and Meta-Analysis of Randomized Controlled Trials. https://app.cochat.ai/papers/10.1177/0706743719892471
The paper
Lam, R. W., Teng, M. Y., Jung, Y.-E., Evans, V. C., Gottlieb, J. F., Chakrabarty, T., Michalak, E. E., Murphy, J. K., Yatham, L. N., & Sit, D. K. (2020). Light Therapy for Patients With Bipolar Depression: Systematic Review and Meta-Analysis of Randomized Controlled Trials. The Canadian Journal of Psychiatry. https://doi.org/10.1177/0706743719892471

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.